Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Disease Reports
alcohol-related disorders
MeSH D019973 - alcohol-related disorders
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D019966:
Substance-related disorders
10 Companies
2 Drugs
$
Success rate
D019973:
Alcohol-related disorders
1 Company
1 Drug
$
Success rate
D000435:
Alcoholic intoxication
0 Companies
0 Drugs
Success rate
D000437:
Alcoholism
60 Companies
9 Drugs
$
Success rate
D014899:
Wernicke encephalopathy
19 Companies
16 Drugs
$
Success rate
D020751:
Alcohol-induced disorders
0 Companies
0 Drugs
Success rate
D063425:
Binge drinking
16 Companies
1 Drug
$
Success rate
D000425:
Alcohol amnestic disorder
0 Companies
0 Drugs
Success rate
D000430:
Alcohol withdrawal delirium
58 Companies
8 Drugs
$
Success rate
D011604:
Alcoholic psychoses
0 Companies
0 Drugs
Success rate
Events Timeline
Commercial
No Data
Clinical Trials
Historical Success Rate
Phase 1
40
%
2/5
Phase 2
36
%
4/11
Phase 3
33
%
2/6
Approved:
1
Overall Success rate:
5%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Lundbeck
Nalmefene
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use